# Sevoflurane and Percutaneous Coronary Intervention by Stent

Study · id `cardio:ct-nct02671084` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02671084](<https://clinicaltrials.gov/study/NCT02671084>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02671084

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 701 participants.

## Technical summary

Registry record NCT02671084. Randomized; double masking; primary purpose treatment. Start 2016-02 (actual); primary completion 2020-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 701 participants (enrolled count; ClinicalTrials.gov record NCT02671084, source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)
- Started: 2016-02 (actual) (ClinicalTrials.gov record NCT02671084, source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)
- Primary completion: 2020-04 (actual) (ClinicalTrials.gov record NCT02671084, source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)
- Completion: 2020-04 (actual) (ClinicalTrials.gov record NCT02671084, source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02671084, source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02671084-2020-04-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sevoflurane and Percutaneous Coronary Intervention by Stent
- Condition: Myocardial Infarction
- Intervention (Drug): sevoflurane
- Lead sponsor: Instituto Dante Pazzanese de Cardiologia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Instituto Dante Pazzanese de Cardiologia (`cardio:org-instituto-dante-pazzanese-de-cardiologia`)

## Provenance

Content hash: 6b930225429b5899f77d6b58f0d556394660e849b3e77aa8b392a97cc3f4888a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
